Please login to the form below

Not currently logged in

PureTech appoints Joseph Bolen as entrepreneur-in-residence

And Vincent Hennemand joins as VP, company development and operations

PureTech Health Joseph BolenBoston-based PureTech Health has appointed Joseph Bolen (pictured) as entrepreneur-in-residence.

He previously served as president of research and development at Moderna Therapeutics and as chief scientific officer at Millennium Pharmaceuticals.

Prior to joining Millennium in 1999, Dr. Bolen held senior R&D positions at Hoechst Marion Roussel, Schering-Plough, and Bristol-Myers Squibb.

As PureTech's entrepreneur-in-residence he will work with the firm's company creation team to identify and pursue promising new medicines.

Also joining PureTech, which focuses on developing novel medicines, is Vincent Hennemand.

He was formerly principal in Sanofi's corporate R&D venture group and joins the cross-disciplinary healthcare firm as its vice president of company development and operations.

Prior to that Hennemand was chief of staff to the president of global R&D and the general secretary for the corporate scientific advisory committee (SDSAC), which investigates scientific proposals and projects of potential interest to Sanofi.

9th December 2015

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...